Standout Papers

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy 2022 2026 2023 2024185
  1. Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy (2022)
    Peijie Zheng, Liuyi Lu et al. Journal of Experimental & Clinical Cancer Research

Immediate Impact

59 standout
Sub-graph 1 of 21

Citing Papers

A Self‐Amplifying ROS‐Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy
2024 Standout
Marine natural products
2024 Standout
1 intermediate paper

Works of Liuyi Lu being referenced

Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
2022 Standout
Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway
2017

Author Peers

Author Last Decade Papers Cites
Liuyi Lu 130 36 81 78 16 334
Yibo Du 170 21 42 41 11 316
Élisabeth Miot-Noirault 155 22 73 55 15 358
Zhipeng Sun 157 81 72 45 15 315
Yujun Luo 125 14 44 29 23 274
Yichen Li 178 38 53 20 12 335
Aimin Huang 127 53 33 28 15 365
Mayu Sun 168 77 70 22 12 371
Krishna Priya Mani 89 38 27 46 16 301
Zide Chen 185 48 88 18 19 363
Zhining Liu 157 33 88 18 26 355

All Works

Loading papers...

Rankless by CCL
2026